ArticleFrontiers in public health2022

Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.

Yang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.